Clinical Trial Takeda - Hidradenitis Suppurativa

Study ID: TakedaTAK-279-HS-2001 - Clinical Trial for Hidradenitis Suppurativa

Summary

Study Details

Study Name	Age Requirements	Length of Study	Type of Treatment
Takeda	18+ Years of age	61 Weeks (Up to 12 visits to the clinic)	Oral

Adult’s Hidradenitis Suppurativa Study

Who Can Participate?

People aged 18 and above with moderate to severe Hidradenitis Suppurativa (HS) may participate.

Inclusion Criteria

Participants must have signs and symptoms of HS for at least 6 months
Diagnosis of HS, with stable HS signs and symptoms for 2 months
Participants must have a history of inadequate response to a previous course of oral antibiotic for treatment of HS or exhibited
recurrence, intolerance, or contraindication during that course of oral antibiotic

Participant Information

Participate and receive study treatment at no cost
Regular visits with study doctors who specialise in treating Hidradenitis Suppurativa (up to 12 visits)
Will receive either an investigative oral treatment (study drug) or a placebo
Reimbursement for study-related expenses may be provided

How Long Will The Study Last?

Approximately 61 Weeks

Contact us about joining the trial

To be eligible for this trial, applicants MUST have a skin condition. We DO NOT accept volunteers who do not have a skin disease.

Fill out this form to get in touch or call our clinical trial line at #(289)-763-8666. We will contact you in 1-2 business days regarding your application to participate in the trial.

First Name

Last Name

Phone Number

Email Address

Postal Code

Sex

Best Time to Reach You

Best Contact Method

Check this box to confirm you meet the study requirements, and consent to: recieving text notifications/emails about the trial, and (1) sharing your information with the study site, and (2) our Privacy Policy (see below). All provided information is confidential and will not be shared without your consent.

Privacy Policy for SimcoDerm Clinical Trials

Your privacy is important to us, and we take the protection of your personal health information (PHI) seriously. This policy explains how we collect, use, and protect your information.

We collect information directly from you, including your name, contact details, health information, and treatment history.

We use your information to determine eligibility for clinical trials, manage appointments, and communicate with you about your participation in clinical trials.

Data Protection:

Your information is stored securely and is only accessible by authorized personnel. We use data encryption, conduct security audits, and implement strict access controls to ensure the protection of your personal information.

You have the right to access, amend, or request the deletion of your health records. To exercise these rights, send a request to our clinical trial support team.